Suppr超能文献

能够有效使移植细胞在肝脏中再增殖的模型系统和实验条件。

Model systems and experimental conditions that lead to effective repopulation of the liver by transplanted cells.

机构信息

Marion Bessin Liver Research Center, Department of Medicine and Division of Hepatology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

出版信息

Int J Biochem Cell Biol. 2011 Feb;43(2):198-213. doi: 10.1016/j.biocel.2010.01.013. Epub 2010 Jan 18.

Abstract

In recent years, there has been substantial progress in transplanting cells into the liver with the ultimate goal of restoring liver mass and function in both inherited and acquired liver diseases. The basis for considering that this might be feasible is that the liver is a highly regenerative organ. After massive liver injury or surgical removal of two-thirds or more of the liver tissue, the organ can restore its mass with completely normal morphologic structure and function. It has also been found under highly selective conditions that transplanted hepatocytes can fully repopulate the liver and cure a metabolic disorder or deficiency state. Fetal liver cells can also substantially repopulate the normal liver, and it is hoped in the future that effective repopulation will be achievable with cultured cells or cell lines, pluripotent stem cells from other somatic tissues, embryonic stem cells, or induced pluripotent stem cells, which can now be generated in vitro by a variety of methods. The purpose of this review is to present the major systems that have been used for liver repopulation, the variables involved in obtaining successful repopulation and what has been achieved in these various systems to date with different cell types.

摘要

近年来,在将细胞移植到肝脏中以恢复遗传和获得性肝脏疾病的肝质量和功能方面取得了实质性进展。考虑到这可能是可行的,其基础是肝脏是一个高度再生的器官。在大量肝损伤或手术切除三分之二或更多的肝组织后,该器官可以恢复其具有完全正常形态结构和功能的质量。在高度选择性条件下,也发现移植的肝细胞可以完全再填充肝脏并治愈代谢紊乱或缺乏状态。胎儿肝细胞也可以大量再填充正常肝脏,未来有望通过培养细胞或细胞系、来自其他体细胞的多能干细胞、胚胎干细胞或诱导多能干细胞来实现有效的再填充,这些细胞现在可以通过多种方法在体外生成。本综述的目的是介绍已用于肝脏再填充的主要系统、获得成功再填充所涉及的变量以及迄今为止使用不同细胞类型在这些不同系统中取得的成就。

相似文献

3
Hepatocyte transplantation: waiting for stem cells.肝细胞移植:等待干细胞
Curr Opin Organ Transplant. 2008 Dec;13(6):627-32. doi: 10.1097/MOT.0b013e328317a44f.
5
Therapeutic potential of hepatocyte transplantation.
Semin Cell Dev Biol. 2002 Dec;13(6):439-46. doi: 10.1016/s1084952102001325.
9
Stem cells, cell transplantation and liver repopulation.干细胞、细胞移植与肝脏再填充。
Biochim Biophys Acta. 2008 Feb;1782(2):61-74. doi: 10.1016/j.bbadis.2007.12.004. Epub 2007 Dec 23.

引用本文的文献

1
Cell therapy in end-stage liver disease: replace and remodel.细胞治疗终末期肝病:替代与重塑。
Stem Cell Res Ther. 2023 May 25;14(1):141. doi: 10.1186/s13287-023-03370-z.
2
Sexual Dimorphism in Hepatocyte Xenograft Models.肝细胞异种移植模型中的性别二态性。
Cell Transplant. 2021 Jan-Dec;30:9636897211006132. doi: 10.1177/09636897211006132.
6
Alcoholic liver disease: Utility of animal models.酒精性肝病:动物模型的应用。
World J Gastroenterol. 2018 Dec 7;24(45):5063-5075. doi: 10.3748/wjg.v24.i45.5063.
10
Wilson's disease: Prospective developments towards new therapies.威尔逊病:新疗法的前瞻性进展。
World J Gastroenterol. 2017 Aug 14;23(30):5451-5456. doi: 10.3748/wjg.v23.i30.5451.

本文引用的文献

5
Generation of induced pluripotent stem cells using recombinant proteins.利用重组蛋白生成诱导多能干细胞。
Cell Stem Cell. 2009 May 8;4(5):381-4. doi: 10.1016/j.stem.2009.04.005. Epub 2009 Apr 23.
7
Origin of stem cells in organogenesis.器官发生过程中干细胞的起源。
Science. 2008 Dec 5;322(5907):1498-501. doi: 10.1126/science.1162782.
8
Differentiation and transplantation of human embryonic stem cell-derived hepatocytes.人胚胎干细胞来源肝细胞的分化与移植
Gastroenterology. 2009 Mar;136(3):990-9. doi: 10.1053/j.gastro.2008.10.047. Epub 2008 Oct 29.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验